Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Randy G Mungwira"'
Autor:
Randy G Mungwira, Christine Guillard, Adiela Saldaña, Nobuhiko Okabe, Helen Petousis-Harris, Edinam Agbenu, Lance Rodewald, Patrick L F Zuber
Publikováno v:
PLoS ONE, Vol 15, Iss 5, p e0233334 (2020)
To update the landscape analysis of vaccine injuries no-fault compensation programmes, we conducted a scoping review and a survey of World Health Organization Member States. We describe the characteristics of existing no-fault compensation systems du
Externí odkaz:
https://doaj.org/article/d3525f42f792470eb910462c67740ce8
Autor:
Wongani Nyangulu, Randy G. Mungwira, Titus H. Divala, Nginache Nampota-Nkomba, Osward M. Nyirenda, Andrea G. Buchwald, Jernelle Miller, Dominique E. Earland, Matthew Adams, Christopher V. Plowe, Terrie E. Taylor, Jane E. Mallewa, Joep J. van Oosterhout, Sunil Parikh, Matthew B. Laurens, Miriam K. Laufer, the TSCQ Study Team
Publikováno v:
Malaria Journal, Vol 22, Iss 1, Pp 1-8 (2023)
Abstract Background When people with human immunodeficiency virus (HIV) infection (PWH) develop malaria, they are at risk of poor anti-malarial treatment efficacy resulting from impairment in the immune response and/or drug-drug interactions that alt
Externí odkaz:
https://doaj.org/article/d45684f11b344906871b6bdeccd64271
Autor:
Randy G. Mungwira, Matthew B. Laurens, Wongani Nyangulu, Titus H. Divala, Nginache Nampota-Nkomba, Andrea G. Buchwald, Osward M. Nyirenda, Edson Mwinjiwa, Maxwell Kanjala, Lufina Tsirizani Galileya, Dominique E. Earland, Matthew Adams, Christopher V. Plowe, Terrie E. Taylor, Jane Mallewa, Joep J. van Oosterhout, Miriam K. Laufer
Publikováno v:
AIDS (London, England). 36(12)
Many individuals living with the human immunodeficiency virus (HIV) infection and receiving antiretroviral therapy (ART) reside in areas at high risk for malaria but how malaria affects clinical outcomes is not well described in this population. We e
Autor:
Wongani Nyangulu, Randy G. Mungwira, Titus H. Divala, Nginache Nampota-Nkomba, Osward M. Nyirenda, Andrea G. Buchwald, Jernelle Miller, Dominique E. Earland, Matthew Adams, Christopher V. Plowe, Terrie E. Taylor, Jane Mallewa, Joep J. vanOosterhout, Sunil Parikh, Matthew B. Laurens, Miriam Laufer
BackgroundWhen people with human immunodeficiency virus (HIV) infection (PWH) develop malaria, they are at risk of poor antimalarial treatment efficacy resulting from impairment in the immune response and/or drug-drug interactions that alter antimala
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::23f04cc27cd38235ca0ce06832932435
https://doi.org/10.21203/rs.3.rs-1871547/v1
https://doi.org/10.21203/rs.3.rs-1871547/v1
Autor:
Jane Mallewa, Titus H. Divala, Edson Mwinjiwa, Amy Tillman, Matthew Downs, Felix A. Mkandawire, Randy G. Mungwira, Joep J. van Oosterhout, Matthew B. Laurens, Maxwell Kanjala, Miriam K. Laufer, Wongani Nyangulu, Christopher V. Plowe, Osward M. Nyirenda, Terrie E. Taylor, Nginache Nampota, Lufina Tsirizani Galileya
Publikováno v:
Clin Infect Dis
BackgroundDaily co-trimoxazole is recommended for African adults living with human immunodeficiency virus (HIV) irrespective of antiretroviral treatment, immune status, or disease stage. Benefits of continued prophylaxis and whether co-trimoxazole ca
Autor:
Helen Petousis-Harris, Edinam Agbenu, Adiela Saldaña, Randy G. Mungwira, Lance Rodewald, Christine Guillard, Nobuhiko Okabe, Patrick L.F. Zuber
Publikováno v:
PLoS ONE
PLoS ONE, Vol 15, Iss 5, p e0233334 (2020)
PLoS ONE, Vol 15, Iss 5, p e0233334 (2020)
To update the landscape analysis of vaccine injuries no-fault compensation programmes, we conducted a scoping review and a survey of World Health Organization Member States. We describe the characteristics of existing no-fault compensation systems du
Autor:
Priscilla Mvula, Lufina Tsirizani, Jaya Goswami, Rhoda Masonga, Atis Muehlenbachs, Jessie K. Kennedy, Titus H. Divala, Maxwell Kanjala, Osward M. Nyirenda, Blair J. Wylie, Lughano Ndovie, Sarah Boudova, Miriam K. Laufer, Yamikani Mbilizi, Patricia Mawindo, Randy G. Mungwira, Gail E Potter, Masiye John Ndaferankhande, Francis Muwalo, Tamiwe Tomoka
Publikováno v:
The Lancet Infectious Diseases. 18:1097-1107
BACKGROUND: Sulfadoxine-pyrimethamine resistance threatens efficacy of intermittent preventive treatment of malaria during pregnancy, and alternative regimens need to be identified. With the return of chloroquine efficacy in southern Africa, we postu
Autor:
Randy G. Mungwira, Miriam K. Laufer, Terrie E. Taylor, Titus H. Divala, Augustine T. Choko, Joep J. van Oosterhout, Osward M. Nyirenda, Francis Muwalo, Matthew B. Laurens, Maxwell Kanjala, Felix A. Mkandawire, Jane Mallewa
Publikováno v:
Tropical Medicine & International Health. 23:526-532
OBJECTIVES: WHO recommends HIV viral-load (VL) testing six months after antiretroviral therapy (ART) initiation and every 12 months thereafter, but cost prohibits routine, universal VL testing in many developing countries. We sought to devise a targe
Autor:
Titus H. Divala, Nginanche Nampota, Lufina Tsirizani, Edson Mwinjiwa, Wongani Nyangulu, Osward M. Nyirenda, Randy G. Mungwira
Publikováno v:
BMC Medical Ethics
BMC Medical Ethics, Vol 20, Iss 1, Pp 1-5 (2019)
BMC Medical Ethics, Vol 20, Iss 1, Pp 1-5 (2019)
Background Compensating participants of biomedical research is a common practice. However, its proximity with ethical concerns of coercion, undue influence, and exploitation, demand that participant compensation be regulated. The objective of this pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6979c3d8f26ef7a4a83ce7d22228ff0
Publikováno v:
Vaccine. 37(31)
Improvements in vaccine safety surveillance and investigative capacity lead to identification of rare reactions attributable to vaccination. As a result, the issue of fair compensation for those who experience vaccine injuries is gaining growing atte